Company / Free Cash Flow per Share
Acadia Pharmaceuticals Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.63
FY2025
5-year range
-$0.79 / $0.95
FY2021-FY2025
Trend
-33.9%
vs FY2024
Sector context
#56 of 192
Health Care
What the data says
At $0.63, Acadia Pharmaceuticals's free cash flow per share ranks #56 of 192 in the Health Care sector. Improved from $0.10 to $0.63 over the past 2 years.
Based on SEC 10-K filings.
0.63 in FY2025.
Improved from $0.10 to $0.63 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 192 in Health CareTop 29% of 192This company $0.63 Sector average $3.32
▼
-81.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 33.9% year-over-year.
- Ranks #56 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -33.9% |
| FY2024 | $0.95 | +829.2% |
| FY2023 | $0.10 | +114.5% |
| FY2022 | -$0.71 | +10.8% |
| FY2021 | -$0.79 | +14.2% |
| FY2020 | -$0.93 | +12.5% |
| FY2019 | -$1.06 | +22.3% |
| FY2018 | -$1.36 | +24.3% |
| FY2017 | -$1.80 | +12.5% |
| FY2016 | -$2.06 | -66.2% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026